Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Treatment of patients with Waldenstràm macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group

Talaulikar D, Tam CS, Joshua D, Ho JP, Szer J, Quach H, Spencer A, Harrison S, Mollee P, Roberts AW, Horvath N, Lee C, Zannettino A, Brown R, Augustson B, Jaksic W, Gibson J, Kalff A, Johnston A, Trotman J, Kalro A, Grigoriadis G, Ward C, Prince HM

(2017), Intern Med J, 47(1), 35-49

DOI: 10.1111/imj.13311

Gastrointestinal carriage is a major reservoir of Klebsiella pneumoniae infection in intensive care patients

Gorrie CL, Mirceta M, Wick RR, Edwards DJ, Thomson NR, Strugnell RA, Pratt NF, Garlick JS, Watson KM, Pilcher DV, McGloughlin SA, Spelman DW, Jenney AWJ, Holt KE

(2017), Clin Infect Dis, 65(2), 208-15

DOI: 10.1093/cid/cix270

Clinical characteristics and laboratory identification of Aerococcus infections: an Australian tertiary centre perspective

Narayanasamy S, King K, Dennison A, Spelman DW, Aung AK

(2017), Int J Microbiol, 2017, 5684614

DOI: 10.1155/2017/5684614

Spleen Australia guidelines for the prevention of sepsis in patients with asplenia and hyposplenism in Australia and New Zealand

Kanhutu K, Jones P, Cheng AC, Grannell L, Best E, Spelman D

(2017), Intern Med J, 47(8), 848-55

DOI: 10.1111/imj.13348

Partial response after induction chemotherapy has clinical relevance in acute myeloid leukaemia

Fleming S, Ong DM, Jackson K, Avery S, Mollee P, Marlton P, Kennedy G, Wei AH

(2017), Br J Haematol, 177(2), 328-3 0

Risk factors associated with urinary tract infections in intensive care patients

Lee EK, Teo A, Land G, Borrell S, Spelman D, Leong T, Cheng AC

(2016), Infect Dis Health, 21(2)

Plasma macrophage migration inhibitor factor is elevated in response to myocardial ischemia

Fan F, Fang L, Moore XL, Xie X, Du XJ, White DA, O'Brien J, Thomson H, Wang J, Schneider HG, Ellims A, Barber TW, Dart AM

(2016), J Am Heart Assoc, 5(7)

Impact of high-sensitivity troponin I testing with sex-specific cutoffs on the diagnosis of acute myocardial infarction

Trambas C, Pickering JW, Than M, Bain C, Nie L, Paul E, Dart A, Broughton A, Schneider HG

(2016), Clin Chem, 62(6)

Should routine laboratories stop doing screening serum protein electrophoresis and replace it with screening immune-fixation electrophoresis? No quick fixes: Counterpoint

Smith JD, Raines G, Schneider HG

(2016), Clin Chem Lab Med, 54(6)

Taenia solium taeniasis and cysticercosis in Southeast Asia

Aung AK, Spelman DW

(2016), Am J Trop Med Hyg, 94(5)

Targeting plasma cells: are we any closer to a panacea for diseases of antibody-secreting cells?

Low M, Infantino S, Grigoriadis G, Tarlinton D

(2016), Immunol Rev, 270(1)

Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice

Lee EM, Yee D, Busfield SJ, McManus JF, Cummings N, Vairo G, Wei A, Ramshaw HS, Powell JA, Lopez AF, Lewis ID, McCall MN, Lock RB

(2015), Haematologica, 100(7), 914-26

Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study

Ravandi F, Ritchie EK, Sayar H, Lancet JE, Craig MD, Vey N, Strickland SA, Schiller GJ, Jabbour E, Erba HP, Pigneux A, Horst HA, Recher C, Klimek VM, Cortes J, Roboz GJ, Odenike O, Thomas X, Havelange V, Maertens J, Derigs HG, Heuser M, Damon L, Powell BL, Gaidano G, Carella AM, Wei A, Hogge D, Craig AR, Fox JA, Ward R, Smith JA, Acton G, Mehta C, Stuart RK, Kantarjian HM

(2015), Lancet Oncol, 16(9), 1025-36

Immunological markers for prognostication in cytogenetically normal acute myeloid leukemia

Ling VY, Lee D, McQuilten Z, Avery S, Low M, Cody SH, Nguyen T, McLean C, Gorniak M, Wei A, Ting SB

(2015), Am J Hematol, 90(12), E219-20

Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran

Bouchard J, Ghannoum M, Bernier-Jean A, Williamson D, Kershaw G, Weatherburn C, Eris JM, Tran H, Patel JP, Roberts DM

(2015), Clin Toxicol, 53(3), 156-63

Treating pulmonary embolism in Pacific Asia with direct oral anticoagulants

Cohen A, Jeyaindran S, Kim JY, Park K, Sompradeekul S, Tambunan KL, Tran H, Tsai IC, Ward C, Wong R

(2015), Thromb Res, 136(2), 196-207

Heparin induced thrombocytopenia in critically ill: diagnostic dilemmas and management conundrums

Gupta S, Tiruvoipati R, Green C, Botha J, Tran H

(2015), World J Crit Care Med, 4(3), 202-12

Isolated iliac vein thrombosis in pregnancy

Keragala CB, Cummins KD, Goergen SK, Shipp D, Chunilal S

(2015), Intern Med J, 45(4), 460-1

Maintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemia

Wei A, Tan P, Perruzza S, Govindaraj C, Fleming S, McManus J, Avery S, Patil S, Stevenson W, Plebanski M, Spencer A

(2015), Br J Haematol, 169(2), 199-210

Comparison of biosimilar filgrastim with originator filgrastim for peripheral blood stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous stem cell transplantation

Pham T, Patil S, Fleming S, Avery S, Walker P, Wei A, Curtis D, Stuart G, Klarica D, O'Brien M, Morris K, Das T, Bollard G, Muirhead J, Coutsouvelis J, Spencer A

(2015), Transfusion, 55(11), 2709-13

12 13 14 15 16